These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5730639)

  • 1. [Antibacterial effect in vitro and in vivo of kitasamycin].
    Filadoro F; Cipriani P; Ravagnan L
    Antibiotica; 1968 Mar; 6(1):5-23. PubMed ID: 5730639
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro and in vivo antibacterial activity of staphylomycin].
    Del Piano M; Filadoro F; Monacelli E; Renzini G
    Antibiotica; 1967 Sep; 5(3):178-97. PubMed ID: 4894134
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibacterial activities of new nitrofuran derivatives on Mycoplasm gallisepticum and Haemophilus gallinarum.
    Ota S; Watanabe S; Kuniyasu C
    Natl Inst Anim Health Q (Tokyo); 1970; 10(1):1-10. PubMed ID: 4191833
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of pristamycin on staphylococci in vitro].
    Cybulska J; Jeljaszewicz J
    Med Dosw Mikrobiol; 1967; 19(3):219-24. PubMed ID: 6082376
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kinetics of the antibacterial activity of chloramphenicol and thiamphenicol in vitro and in vivo].
    Yourassowsky E; Monsieur R
    Arzneimittelforschung; 1970 Aug; 20(8):1106-9. PubMed ID: 5536513
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of Vibramycin].
    Baumann PC; Haemmerli UP
    Chemotherapia (Basel); 1968; 13():Suppl:53-8. PubMed ID: 5666831
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-activity relationships in membrane-perturbing agents. Hemolytic, narcotic, and antibacterial compounds.
    Hansch C; Glave WR
    Mol Pharmacol; 1971 May; 7(3):337-54. PubMed ID: 5106355
    [No Abstract]   [Full Text] [Related]  

  • 8. Susceptibility of Haemophilus equigenitalis, the causal agent of contagious equine metritis, to 31 antimicrobial agents.
    Sugimoto C; Isayama Y; Kashiwazaki M; Mitani K
    Natl Inst Anim Health Q (Tokyo); 1981; 21(4):159-62. PubMed ID: 7341991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides.
    Beebe X; Yang F; Bui MH; Mitten MJ; Ma Z; Nilius AM; Djuric SW
    Bioorg Med Chem Lett; 2004 May; 14(10):2417-21. PubMed ID: 15109624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative toxicological, chemotherapeutic and pharmacokinetic studies with sulphormethoxine and other sulphonamides in animals and man.
    Böhni E; Fust B; Rieder J; Schaerer K; Havas L
    Chemotherapy; 1969; 14(4):195-226. PubMed ID: 4981614
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on new antibiotics, cineromycins A and B.
    Miyairi N; Takashima M; Shimizu K; Sakai H
    J Antibiot (Tokyo); 1966 Mar; 19(2):56-62. PubMed ID: 5952892
    [No Abstract]   [Full Text] [Related]  

  • 12. [The antibacterial effect of ethonium on Staphylococcus aureus].
    Gladyshevskaia-Veselovska ; Kucher VI; Pis'ko GT
    Mikrobiol Zh; 1970; 32(3):388-90. PubMed ID: 5517386
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis, in vitro, and in vivo antibacterial activity of nocathiacin I thiol-Michael adducts.
    Naidu BN; Sorenson ME; Bronson JJ; Pucci MJ; Clark JM; Ueda Y
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2069-72. PubMed ID: 15808470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of clinical isolates of staphylococci and Haemophilus influenzae to newer quinolones.
    Basta M; Herman T; Heczko PB
    J Chemother; 1989 Jul; 1(4 Suppl):376-7. PubMed ID: 16312447
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of phosphonomycin, a new antibacterial antibiotic.
    Raab W; Windisch J
    Pathol Microbiol (Basel); 1971; 37(5):368-75. PubMed ID: 4108480
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibacterial activity of cholane derivatives. III. Amidie and amine derivatives of cholic, desoxycholic, chenodesoxycholic and ursodesoxycholic acids].
    Cavazzini G; Bellini AM; Quaglio MP; Guarneri M
    Nuovi Ann Ig Microbiol; 1982; 33(2-3):419-33. PubMed ID: 6821214
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the in vitro sensitivity of Staphylococcus aureus strains of bovine mammary origin to different antibiotics.
    Rao CC; Khera SS; Sharma GL
    Indian Vet J; 1966 Mar; 43(3):181-90. PubMed ID: 5931150
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biological properties of pyogenic staphylococci resistant to imanin and novoimanin].
    Kudriavtsev VO
    Mikrobiol Zh; 1965; 27(6):43-8. PubMed ID: 5869038
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of cefovecin in dogs.
    Stegemann MR; Sherington J; Blanchflower S
    J Vet Pharmacol Ther; 2006 Dec; 29(6):501-11. PubMed ID: 17083454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the antibacterial activity of a strain of Micrococcus sp. in regard to Staphylococcus aureus; compared with antibacterial activity of 24 antibiotics of current use].
    Gabbrielli G; Foresi C
    Nuovi Ann Ig Microbiol; 1965; 16(3):211-5. PubMed ID: 5861162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.